ESR1 and breast cancer: Interestingly, EPOR knockdown experiments showed that reduced EPOR expression in estrogen receptor-positive breast cancer cells resulted in decreased proliferation of these cancer cells, but the same effect has not been observed in estrogen receptor-negative breast cancer cells, indicating that EPOR signaling is strongly dependent on breast cancer biology (Reinbothe et al., 2014).